Ondansetron
Product Images NDC 67296-1140

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 67296-1140). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (4 mg (30 Tablets Bottle))

This is a description of Ondansetron orally disintegrating tablets, USP with a pack of 30 tablets. The tablets contain Ondansetron USP 4 mg each. It is important to store the tablets at a temperature of 20°C to 25°C (68°F to 77°F) with excursions permitted to 15°C to 30°C (69°F to 86°F). The tablets meet USP Disintegration Test 2 and should be dispensed in a tight, light-resistant container. The usual dosage instructions can be found in the package insert. These tablets are distributed by Rising Heath, LLC in Saddle Brook, NJ 07663 and are made in India.*

FDA Label Image

Package Label-principal Display Panel (4 mg Blister Carton (3 x 10 Unit-dose))

FDA Label Image

Package Label-principal Display Panel (8 mg (30 Tablets Bottle))

This text appears to be a label for Rising® Noc57237-078-30 orally disintegrating tablets containing Ondansetron USP. It includes information about the dosage, phenylalanine content, storage instructions, and packaging details. The tablets meet USP Disintegration Test 2 and should be dispensed from a tight, light-resistant container.*

FDA Label Image

Package Label-principal Display Panel (8 mg Blister Carton (3 x 10 Unit-dose))

FDA Label Image

Chemical Structure (Ondansetronod Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.